Cubist Systematic Strategies, LLC Alaunos Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.43 - $0.65 $17,740 - $26,817	41,257 New	41,257 $21,000
Q3 2022 Nov 14, 2022	BUY	$1.04 - $322.5 $356,102 - $110 Million	342,406 Added 4589.28%	349,867 $602,000
Q2 2022 Aug 15, 2022	SELL	$0.41 - $1.24 $14,860 - $44,945	-36,246 Reduced 82.93%	7,461 $9,000
Q1 2022 May 16, 2022	SELL	$0.62 - $1.17 $68,144 - $128,595	-109,911 Reduced 71.55%	43,707 $29,000
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.89 $153,156 - $265,565	140,511 Added 1072.03%	153,618 $167,000
Q3 2021 Nov 15, 2021	SELL	$1.44 - $2.73 $31,288 - $59,317	-21,728 Reduced 62.37%	13,107 $24,000
Q2 2021 Aug 16, 2021	SELL	$2.63 - $3.67 $35,660 - $49,761	-13,559 Reduced 28.02%	34,835 $92,000
Q1 2021 May 17, 2021	SELL	$2.82 - $5.6 $3,330 - $6,613	-1,181 Reduced 2.38%	48,394 $174,000
Q4 2020 Feb 16, 2021	SELL	$2.09 - $3.09 $40,215 - $59,457	-19,242 Reduced 27.96%	49,575 $125,000
Q3 2020 Nov 16, 2020	BUY	$2.39 - $3.43 $139,855 - $200,713	58,517 Added 568.13%	68,817 $173,000
Q2 2020 Aug 14, 2020	SELL	$2.2 - $3.71 $109,694 - $184,984	-49,861 Reduced 82.88%	10,300 $34,000
Q1 2020 May 15, 2020	BUY	$1.9 - $4.98 $114,305 - $299,601	60,161 New	60,161 $147,000
Q3 2019 Nov 14, 2019	SELL	$4.13 - $6.94 $399,441 - $671,215	-96,717 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$3.98 - $6.2 $384,933 - $599,645	96,717 New	96,717 $564,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $458M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.